New homeopathic medicines: Use of modern drugs according to the principle of similitude

Homeopathy

Volumn 100, Issue 4, 2011, Pages 244-252

  Teixeira, Marcus Zulian ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Homeopathy; New homeopathic medicines; Paradoxical reaction; Rebound effect; Secondary effect; Similitude; Withdrawal syndrome

Indexed keywords

ADVERSE OUTCOME; ARTICLE; CHRONIC DISEASE; DISEASE CLASSIFICATION; HOMEOPATHY; ILLNESS TRAJECTORY; MODERN TIMES; PATHOGENESIS; REFERENCE DATABASE; SYSTEMATIZED NOMENCLATURE OF MEDICINE; THEORY; THERAPEUTIC SIMILITUDE;

DRUG APPROVAL; DRUG COMPOUNDING; HOMEOPATHY; HUMANS; MATERIA MEDICA; PRODUCT SURVEILLANCE, POSTMARKETING; SOLUTIONS; UNITED STATES;

EID: 79960626362     PISSN: 14754916     EISSN: 14764245     Source Type: Journal    
DOI: 10.1016/j.homp.2011.01.002     Document Type: Article

References (38)

1. Hahnemann S. Organon of medicine 1991, [Boericke W, Trans.], B. Jain Publishers, New Delhi. 6th edn.
2. Hahnemann S. Essay on a new principle for ascertaining the curative power of drugs, with a few glances at those hitherto employed. The Lesser Writings of Samuel Hahnemann 1995, B. Jain Publishers, New Delhi, [Reprint edition]. R.E. Dudgeon (Ed.).
3. Teixeira M.Z. Semelhante cura semelhante: o princípio de cura homeopático fundamentado pela racionalidade médica e científica 1998, Editorial Petrus, São Paulo.
4. Teixeira M.Z. Similitude in modern pharmacology. Homeopathy 1999, 88(3):112-120.
5. Teixeira M.Z. Evidence of the principle of similitude in modern fatal iatrogenic events. Homeopathy 2006, 95(4):229-236.
6. Teixeira M.Z. NSAIDs, myocardial infarction, rebound effect and similitude. Homeopathy 2007, 96(1):67-68.
7. Teixeira M.Z. Bronchodilators, fatal asthma, rebound effect and similitude. Homeopathy 2007, 96(2):135-137.
8. Teixeira M.Z. Antidepressants, suicidality and rebound effect: evidence of similitude?. Homeopathy 2009, 98(1):114-121.
9. Teixeira M.Z. Statins withdrawal, vascular complications, rebound effect and similitude. Homeopathy 2010, 99(4):255-262.
10. Teixeira M.Z. Homeopathic use of modern medicines: utilisation of the curative rebound effect. Med Hypotheses 2003, 60(2):276-283.
11. Teixeira M.Z. 'Paradoxical strategy for treating chronic diseases': a therapeutic model used in homeopathy for more than two centuries. Homeopathy 2005, 94(4):265-266.
12. Dudgeon R.E. Lectures on the theory and practice of homoeopathy 1982, B. Jain Publishers, New Delhi, [Reprint edition]. Lectures VII e XII.
13. Hughes R. A manual of pharmacodynamics 1980, B. Jain Publishers, New Delhi, [Second reprint edition]. Lecture II. 6th edn.
14. Hahnemann S. Some kinds of continued and remittent fevers. The Lesser Writings of Samuel Hahnemann 1995, B. Jain Publishers, New Delhi, [Reprint edition]. R.E. Dudgeon (Ed.).
15. Hahnemann S. Cure and prevention of scarlet-fever. The Lesser Writings of Samuel Hahnemann 1995, B. Jain Publishers, New Delhi, [Reprint edition]. R.E. Dudgeon (Ed.).
16. Hahnemann S. On the power of small doses of medicine in general, and of Belladonna in particular. The Lesser Writings of Samuel Hahnemann 1995, B. Jain Publishers, New Delhi, [Reprint edition]. R.E. Dudgeon (Ed.).
17. Hahnemann S. Treatment of the typhus or hospital fever at present prevailing. The Lesser Writings of Samuel Hahnemann 1995, B. Jain Publishers, New Delhi, [Reprint edition]. R.E. Dudgeon (Ed.).
18. Hahnemann S. How can small doses of such very attenuated medicines as homoeopathy employs have any action on the sick?. The Lesser Writings of Samuel Hahnemann 1995, B. Jain Publishers, New Delhi, [Reprint edition]. R.E. Dudgeon (Ed.).
19. Hahnemann S. The medicine of experience. The Lesser Writings of Samuel Hahnemann 1995, B. Jain Publishers, New Delhi, [Reprint edition]. R.E. Dudgeon (Ed.).
20. Wettemann M. Hahnemann's use of 'Fragmenta de viribus medicamentorum' in his early medical practice: analysis based on a patient file. Med Ges Ghesch 2001, 20:221-230.
21. Hahnemann S. Reine Arzneimittellehre 1830, [German Edition], Scholarly Publishing Office, University of Michigan Library, Ann Arbor, p. 472.
22. Hahnemann S. Materia Medica Pura 1994, B. Jain Publishers, New Delhi, [Reprint edition]. 2v.
23. Hahnemann S. Chronic diseases 1983, [Dudgeon RE, Trans.], B. Jain Publishers, New Delhi, 2v.
24. World Health Organization (WHO), The Uppsala Monitoring Centre The importance of pharmacovigilance. Safety monitoring of medicinal products 2002, Available from:. http://apps.who.int/medicinedocs/pdf/s4893e/s4893e.pdf.
25. European Medicines Agency Guideline for good clinical practice 2002, Available from:, London. http://www.ema.europa.eu/pdfs/human/ich/013595en.pdf.
26. World Health Organization (WHO), Council for International Organizations of Medical Sciences International ethical guidelines for biomedical research involving human subjects 2002, Available from:, Geneva. http://www.cioms.ch/publications/guidelines/guidelines_nov_2002_blurb.htm.
27. World Health Organization (WHO) Guidelines for good clinical practice (GCP) for trials on pharmaceutical products 1995, Technical report series, No. 850, annex 3. Available from:, WHO. http://apps.who.int/medicinedocs/pdf/whozip13e/whozip13e.pdf.
28. United States Code of Federal Regulations. 21 CFR. Food and drugs. 312 Investigational new drug application 2003, Available from:, Washington. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/cfrsearch.cfm%3Fcfrpart%3D312.
29. Marodin G., Goldim J.R. Confusions and ambiguities in the classification of adverse events in the clinical research. Rev Esc Enferm USP 2009, 43(3):690-696. Available from:. http://www.scielo.br/pdf/reeusp/v43n3/en_a27v43n3.pdf.
30. The United States Pharmacopeial Convention The United States pharmacopeia dispensing information 2004, Mack Printing Co., Easton.
31. World Health Organization (WHO), Council for International Organizations of Medical Sciences Guidelines for preparing core clinical safety information on drug from CIOMS working group III 1995, Available from:, Geneva. https://apps.who.int/dsa/cat98/zcioms8.htm.
32. World Health Organization (WHO), The Uppsala Monitoring Centre Safety monitoring of medicinal products. Guidelines for setting up and running a Pharmacovigilance Centre 2000, Available from:. http://apps.who.int/medicinedocs/en/d/Jh2934e/.
33. 2010, American Hospital Formulary Service drug information, American Society of Hospital Pharmacists, Bethesda.
34. British Pharmacopoeia Commission The British pharmacopoeia 2010, The Stationery Office, Belfast.
35. European Pharmacopoeia Commission European pharmacopoeia 2009, The Stationery Office, Belfast. 6th edn.
36. Sweetman S.C. Martindale: the complete drug reference 2009, The Pharmaceutical Press, London. 36th edn.
37. United States, Food and Drug Administration MedWatch: the FDA safety information and adverse event reporting program 2009, Form FDA 3500A - mandatory reporting. Available from:, Washington. http://www.fda.gov/downloads/Safety/MedWatch/HowToReport/DownloadForms/UCM082728.pdf.
38. Teixeira M.Z. New homeopathic medicines: use of modern drugs according to principle of similitude 2010, Available from:, Marcus Zulian Teixeira, São Paulo, 3v. http://www.newhomeopathicmedicines.com.